ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

Reagan Family History Shows String Risk Factor

August 2, 1985

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

Radiation Improves Survival In Advanced Prostate Cancer

June 25, 2010

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

AIDS Research Loan Repayment Program

January 10, 1992